Growth Metrics

Cytosorbents (CTSO) EBITDA Margin Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -343.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -178.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -283.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 72.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,505.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -184.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -3,846.00
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 4,917.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4,917.00
Dec 31, 2025 2,020.00
Sep 30, 2025 8,100.00
Jun 30, 2025 6,078.00
Mar 31, 2025 4,509.00
Dec 31, 2024 5,158.00
Sep 30, 2024 -69.00
Jun 30, 2024 58.00
Mar 31, 2024 -2,489.00
Dec 31, 2023 -8,650.00
Sep 30, 2023 -6,484.00
Jun 30, 2023 -3,596.00
Mar 31, 2023 -5,086.00
Dec 31, 2022 -605.00
Sep 30, 2022 -1,153.00
Jun 30, 2022 -3,744.00
Mar 31, 2022 -147.00
Dec 31, 2021 -341.00
Sep 30, 2021 -480.00
Jun 30, 2021 4,869.00
Mar 31, 2021 4,034.00
Dec 31, 2020 5,081.00
Sep 30, 2020 4,246.00
Jun 30, 2020 3,209.00
Mar 31, 2020 2,055.00
Dec 31, 2019 8,203.00
Sep 30, 2019 -639.00
Jun 30, 2019 6,779.00
Mar 31, 2019 2,683.00
Dec 31, 2018 9,692.00
Sep 30, 2018 16,504.00
Jun 30, 2018 -23,052.00
Mar 31, 2018 53,749.00
Dec 31, 2017 48,048.00
Sep 30, 2017 5,771.00
Jun 30, 2017 11,472.00
Mar 31, 2017 3,852.00
Dec 31, 2016 -10,454.00
Sep 30, 2016 4,330.00
Jun 30, 2016 97,769.00
Mar 31, 2016 81,138.00
Dec 31, 2015 44,341.00
Sep 30, 2015 455,065.00
Jun 30, 2015 223,550.00
Mar 31, 2015 223,561.00
Dec 31, 2014 213,095.00